Xeris Pharmaceuticals Inc. (XERS) Misses Q3 EPS by 1c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq rise as tech stocks gain ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| (NASDAQ: XERS) | Delayed: 10.42 +0.25 (2.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.17 | 52 Week High | $ | |||
| Open | $10.17 | 52 Week Low | $ | |||
| Day High | $10.56 | P/E | N/A | |||
| Day Low | $10.17 | EPS | $ | |||
| Volume | 698,034 | |||||
